TriVascular Technologies (TRIV) Reports In-Line Q2 EPS

TriVascular Technologies (NASDAQ: TRIV) reported Q2 EPS of ($0.73), in-line with the analyst estimate of ($0.73). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $8.78 million.

For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.

You May Also Be Interested In

• First Industrial Realty (FR) Tops Q1 EPS by 21c
• First Bancorp (FNLC) Reports Q1 EPS of $0.54
• Logansport Financial Corp. (LOGN) Reports Q1 EPS of $0.44